A blood test combining a standard PSA reading with Randox's Prostate Cancer Risk Score, aimed at men who want more context around their prostate cancer risk before deciding on further tests.
2 biomarkers as listed by Randox Health.
This test looks at two things: your PSA level and Randox's own Prostate Cancer Risk Score, which combines PSA with other factors to try to give a clearer read than PSA alone. PSA is a marker commonly used to help assess prostate health, though levels can be raised by causes other than cancer, such as infection or an enlarged prostate.
With two biomarkers, it sits in the middle of the men's health tests we track for clinical depth. It scores well for clarity and documentation, since the listing sets out the biomarkers, sample type, collection and turnaround clearly, though it does not describe what the report itself looks like.
Its value for money score is below average, reflecting a price above the typical cost of similarly sized men's health tests we track. It also scores low on results and follow-up, because the results are not doctor-reviewed as standard, so you will need to interpret the risk score yourself or take it to your GP. Trust signals are strong, based on Randox's Trustpilot rating and its accredited lab status.
This suits men who have already had a PSA test come back raised and want a second data point before deciding on further investigation, or who want a more rounded view of prostate risk than PSA alone provides. We have no directly comparable tests in our data for this exact combination, so we cannot say whether it is cheaper or deeper than alternatives. If you have symptoms or a family history of prostate cancer, discuss testing options with your GP first.
This is a blood test taken by venous draw at a Randox clinic. After the sample reaches the lab, PSA and the Prostate Cancer Risk Score are measured together, with results back within 2 to 3 working days. The provider does not state that results are reviewed by a doctor as standard, so you will need to interpret them yourself or bring them to your GP.
This test pairs the standard PSA marker with Randox's own Prostate Cancer Risk Score for £97, aimed at men wanting more clarity on a raised PSA. It has no group peers in our data to benchmark against directly, and it comes without a doctor review as standard, so you would need to interpret the risk score yourself or discuss it with your GP.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
2 biomarkers, placing it in the 50th percentile of mens health tests we track.
Requires a venous draw at a clinic; results in around 3 days, slower than similar tests.
Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.
Trustpilot 4.6 from 29,705 reviews; accredited lab (UKAS ISO 15189 (Randox Clinical Laboratory Services, lab 9329)); CQC registered.
£97.00 against a median of £65.00 for the 13 similarly sized mens health tests we track (+49%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
One of the deepest men's health panels we track
A 21-marker blood test covering testosterone, cholesterol, liver health, inflammation and vitamin D, for men wanting a broad check on long-term health risk.
50-marker hormone and inflammation panel for skin concerns
A 50-marker blood panel covering hormones, thyroid, inflammation, iron, liver, kidney and vitamin levels that can influence skin condition. Suited to anyone investigating persistent skin issues such as breakouts or dryness.
PSA test priced at the group's £59 median
A single blood test measuring prostate specific antigen (PSA), a marker commonly used to help assess prostate cancer risk. Suited to men aged 45 and over, or 40 and over if at higher risk, as part of regular monitoring.
Cheaper than most PSA tests we track, but not the cheapest
Measures PSA, a protein produced by the prostate, commonly used to assess prostate health. Suited to those in a higher-risk group by age, ethnicity or family history.
